Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferrand

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Experimental Hematology|April 13, 2001
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cellsH Tayebi, F Kuttler, P Saas, et al.
Clinical and Experimental Immunology|October 25, 2007
Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytesS Audia, A Nicolas, D Cathelin, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Cell Death and Differentiation|June 18, 2005
Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansionF Kleinclauss, S Perruche, E Masson, et al.
Gene Therapy|November 14, 2014
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Experimental Hematology|April 13, 2001
Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cellsH Tayebi, F Kuttler, P Saas, et al.
Clinical and Experimental Immunology|October 25, 2007
Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytesS Audia, A Nicolas, D Cathelin, et al.
Hematology and Cell Therapy|October 1, 1996
[Utilization of herpes simplex virus-1 thymidine kinase gene in stem cell transplantation therapy]P Tiberghien, J Y Cahn, C Ferrand, et al.
Cell Death and Differentiation|June 18, 2005
Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansionF Kleinclauss, S Perruche, E Masson, et al.
Gene Therapy|November 14, 2014
Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
Blood|January 3, 2001
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graftP Tiberghien, C Ferrand, B Lioure, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
Pageof 7